243 related articles for article (PubMed ID: 29786867)
1. Growth hormone-releasing hormone antagonists reduce prostatic enlargement and inflammation in carrageenan-induced chronic prostatitis.
Popovics P; Cai R; Sha W; Rick FG; Schally AV
Prostate; 2018 Sep; 78(13):970-980. PubMed ID: 29786867
[TBL] [Abstract][Full Text] [Related]
2. Antagonists of growth hormone-releasing hormone inhibit proliferation induced by inflammation in prostatic epithelial cells.
Popovics P; Schally AV; Salgueiro L; Kovacs K; Rick FG
Proc Natl Acad Sci U S A; 2017 Feb; 114(6):1359-1364. PubMed ID: 28123062
[TBL] [Abstract][Full Text] [Related]
3. Antagonists of growth hormone-releasing hormone (GHRH) reduce prostate size in experimental benign prostatic hyperplasia.
Rick FG; Schally AV; Block NL; Nadji M; Szepeshazi K; Zarandi M; Vidaurre I; Perez R; Halmos G; Szalontay L
Proc Natl Acad Sci U S A; 2011 Mar; 108(9):3755-60. PubMed ID: 21321192
[TBL] [Abstract][Full Text] [Related]
4. Antagonists of growth hormone-releasing hormone inhibit the proliferation of human benign prostatic hyperplasia cells.
Siejka A; Schally AV; Block NL; Barabutis N
Prostate; 2010 Jul; 70(10):1087-93. PubMed ID: 20232355
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of synergism between antagonists of growth hormone-releasing hormone and antagonists of luteinizing hormone-releasing hormone in shrinking experimental benign prostatic hyperplasia.
Rick FG; Schally AV; Block NL; Abi-Chaker A; Krishan A; Szalontay L
Prostate; 2013 Jun; 73(8):873-83. PubMed ID: 23280565
[TBL] [Abstract][Full Text] [Related]
6. Qianliexin capsule exerts anti-inflammatory activity in chronic non-bacterial prostatitis and benign prostatic hyperplasia via NF-κB and inflammasome.
Zang L; Tian F; Yao Y; Chen Y; Shen Y; Han M; Meng Z; Fan S; Zhang X; Cai T; Gao Q; Zhang Y; Lu J
J Cell Mol Med; 2021 Jun; 25(12):5753-5768. PubMed ID: 33982874
[TBL] [Abstract][Full Text] [Related]
7. Traditional Chinese Medicine Danzhi qing'e decoction inhibits inflammation-associated prostatic hyperplasia via inactivation of ERK1/2 signal pathway.
Liu Y; Shao R; Suo T; Zhu J; Liu E; Wang Y; Miao L; Gao X
J Ethnopharmacol; 2023 Jun; 309():116354. PubMed ID: 36906158
[TBL] [Abstract][Full Text] [Related]
8. Influence of E. coli-induced prostatic inflammation on expression of androgen-responsive genes and transforming growth factor beta 1 cascade genes in rats.
Funahashi Y; Wang Z; O'Malley KJ; Tyagi P; DeFranco DB; Gingrich JR; Takahashi R; Majima T; Gotoh M; Yoshimura N
Prostate; 2015 Mar; 75(4):381-9. PubMed ID: 25451715
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of androgen-responsive genes and transforming growth factor-β1 cascade genes in a rat model of non-bacterial prostatic inflammation.
Funahashi Y; O'Malley KJ; Kawamorita N; Tyagi P; DeFranco DB; Takahashi R; Gotoh M; Wang Z; Yoshimura N
Prostate; 2014 Apr; 74(4):337-45. PubMed ID: 24446128
[TBL] [Abstract][Full Text] [Related]
10. Combining growth hormone-releasing hormone antagonist with luteinizing hormone-releasing hormone antagonist greatly augments benign prostatic hyperplasia shrinkage.
Rick FG; Szalontay L; Schally AV; Block NL; Nadji M; Szepeshazi K; Vidaurre I; Zarandi M; Kovacs M; Rekasi Z
J Urol; 2012 Apr; 187(4):1498-504. PubMed ID: 22341819
[TBL] [Abstract][Full Text] [Related]
11. Chronic inflammation promotes proliferation in the prostatic stroma in rats with experimental autoimmune prostatitis: study for a novel method of inducing benign prostatic hyperplasia in a rat model.
Zhang M; Luo C; Cui K; Xiong T; Chen Z
World J Urol; 2020 Nov; 38(11):2933-2943. PubMed ID: 31965289
[TBL] [Abstract][Full Text] [Related]
12. Multitargeted protective effect of Abacopteris penangiana against carrageenan-induced chronic prostatitis in rats.
Yang X; Yuan L; Chen J; Xiong C; Ruan J
J Ethnopharmacol; 2014; 151(1):343-51. PubMed ID: 24211397
[TBL] [Abstract][Full Text] [Related]
13. Targeting androgen receptor to suppress macrophage-induced EMT and benign prostatic hyperplasia (BPH) development.
Lu T; Lin WJ; Izumi K; Wang X; Xu D; Fang LY; Li L; Jiang Q; Jin J; Chang C
Mol Endocrinol; 2012 Oct; 26(10):1707-15. PubMed ID: 22915828
[TBL] [Abstract][Full Text] [Related]
14. Hesperidin ameliorates benign prostatic hyperplasia by attenuating cell proliferation, inflammatory response, and epithelial-mesenchymal transition via the TGF-β1/Smad signaling pathway.
Kim HJ; Jin BR; An HJ
Biomed Pharmacother; 2023 Apr; 160():114389. PubMed ID: 36791565
[TBL] [Abstract][Full Text] [Related]
15. Curcumin attenuates prostatic hyperplasia caused by inflammation
Liu Y; Wang Z; Gan Y; Chen X; Zhang B; Chen Z; Liu P; Li B; Ru F; He Y
Pharm Biol; 2021 Dec; 59(1):1026-1035. PubMed ID: 34357837
[TBL] [Abstract][Full Text] [Related]
16. Potential ameliorative effects of epigallocatechin‑3‑gallate against testosterone-induced benign prostatic hyperplasia and fibrosis in rats.
Zhou J; Lei Y; Chen J; Zhou X
Int Immunopharmacol; 2018 Nov; 64():162-169. PubMed ID: 30179845
[TBL] [Abstract][Full Text] [Related]
17. Tight junction protein claudin-1 is downregulated by TGF-β1 via MEK signaling in benign prostatic epithelial cells.
Wang K; Pascal LE; Li F; Chen W; Dhir R; Balasubramani GK; DeFranco DB; Yoshimura N; He D; Wang Z
Prostate; 2020 Oct; 80(14):1203-1215. PubMed ID: 32692865
[TBL] [Abstract][Full Text] [Related]
18. Effects of acute and chronic administration of a new potent antagonist of growth hormone-releasing hormone in rats: mechanisms of action.
Kovacs M; Zarándi M; Halmos G; Groot K; Schally AV
Endocrinology; 1996 Dec; 137(12):5364-9. PubMed ID: 8940358
[TBL] [Abstract][Full Text] [Related]
19. Upregulated Interleukin 21 Receptor Enhances Proliferation and Epithelial-Mesenchymal Transition Process in Benign Prostatic Hyperplasia.
Xu D; Chen P; Xiao H; Wang X; DiSanto ME; Zhang X
Front Endocrinol (Lausanne); 2019; 10():4. PubMed ID: 30728806
[No Abstract] [Full Text] [Related]
20. Therapeutic Effects of 25-Hydroxyvitamin D on the Pathological Process of Benign Prostatic Hyperplasia: An In Vitro Evidence.
Chen Y; Xu H; Liu C; Gu M; Chen Q; Zhan M; Wang Z
Dis Markers; 2021; 2021():4029470. PubMed ID: 34671434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
